LAUNCHub Ventures

LAUNCHub Ventures is a venture capital firm established in 2012 and headquartered in Sofia, Bulgaria. It specializes in early-stage investments, targeting technology startups in the Seed and Series A funding stages primarily located in Central and Southeastern Europe. The firm focuses on ambitious founders and scalable businesses with initial traction, providing initial investments ranging from €300K to €2M, with the capacity to lead funding rounds up to €4M. LAUNCHub Ventures emphasizes not only financial support but also active partnership with portfolio companies, assisting them in achieving their milestones and securing subsequent funding through programs like their 'Series A academy'. The firm has played a significant role in enhancing the startup ecosystem in the CEE region and has attracted attention from major venture capital firms in Europe and the United States.

Todor Breshkov

Co-Founder and Managing Partner

Irina Dimitrova

CFO

Stephane Gantchev

Partner

Rumen Iliev

Partner

Stanislav Sirakov

General Partner

Raya Yunakova

Investor

Lyuben Belov

Managing Partner and Founding Partner

Past deals in Former Yugoslavia

Mediately

Series A in 2022
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.

Mediately

Seed Round in 2017
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.

Mediately

Seed Round in 2015
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.

Mediately

Seed Round in 2014
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.